NCT04231539View on ClinicalTrials.gov

Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

August 18, 2024

Study Completion Date

August 18, 2024

Conditions
Nicotine Dependence
Interventions
DRUG

Nicotine

Vape different flavor nicotine products

DEVICE

Vaporizer Device

Take puffs from vaporizer filled with different flavors

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER